125 related articles for article (PubMed ID: 7700180)
1. Bone marrow metastasis of neuroblastoma analyzed by MRI and its influence on prognosis.
Tanabe M; Ohnuma N; Iwai J; Yoshida H; Takahashi H; Maie M; Etoh T; Kawamura K
Med Pediatr Oncol; 1995 May; 24(5):292-9. PubMed ID: 7700180
[TBL] [Abstract][Full Text] [Related]
2. Prospective investigation of applicability and the prognostic significance of bone marrow involvement in patients with neuroblastoma detected by quantitative reverse transcription PCR.
Druy AE; Shorikov EV; Tsaur GA; Popov AM; Zaychikov AN; Tuponogov SN; Saveliev LI; Tytgat GAM; Fechina LG
Pediatr Blood Cancer; 2018 Nov; 65(11):e27354. PubMed ID: 30007008
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of bone marrow metastasis of neuroblastoma and changes after chemotherapy by MRI.
Tanabe M; Takahashi H; Ohnuma N; Iwai J; Yoshida H
Med Pediatr Oncol; 1993; 21(1):54-9. PubMed ID: 8426575
[TBL] [Abstract][Full Text] [Related]
4. [MR imaging in patients with bone marrow metastases of neuroblastoma].
Kanegawa K; Nishiyama S; Koshino T; Mabuchi O; Muraji T
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 May; 56(6):368-72. PubMed ID: 8710458
[TBL] [Abstract][Full Text] [Related]
5. [Magnetic resonance imaging for bone marrow metastases of neuroblastoma].
Couanet D; Geoffray A
Bull Cancer; 1988; 75(1):91-6. PubMed ID: 3359059
[TBL] [Abstract][Full Text] [Related]
6. Presence of differentiating neuroblasts in bone marrow is a favorable prognostic factor for bone marrow metastatic neuroblastoma at diagnosis.
Park SH; Kim S; Park CJ; Jang S; Chi HS; Koh KN; Im HJ; Seo JJ
Ann Lab Med; 2013 Mar; 33(2):89-96. PubMed ID: 23483759
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two methods for evaluating bone marrow metastasis of neuroblastoma: Reverse transcription-polymerase chain reaction for tyrosine hydroxylase and magnetic resonance imaging.
Takemoto C; Nishiuchi R; Endo C; Oda M; Seino Y
Pediatr Int; 2004 Aug; 46(4):387-93. PubMed ID: 15310300
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow metastases in children's neuroblastoma studied by magnetic resonance imaging.
Couanet D; Geoffray A; Hartmann O; Leclère JG; Lumbroso JD
Prog Clin Biol Res; 1988; 271():547-55. PubMed ID: 3406018
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of bone marrow lesions in children with neuroblastoma detected by flow cytometry].
Popov AM; Shorikov EV; Verzhditskaia TIu; Tsaur GA; Druĭ AE; Solodovnikov AG; Savel'ev LI; Fechina LG
Vopr Onkol; 2014; 60(4):469-75. PubMed ID: 25552066
[TBL] [Abstract][Full Text] [Related]
10. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
[TBL] [Abstract][Full Text] [Related]
11. Minimal residual disease is a prognostic marker for neuroblastoma with bone marrow infiltration.
Cai JY; Pan C; Tang YJ; Chen J; Ye QD; Zhou M; Xue H; Tang JY
Am J Clin Oncol; 2012 Jun; 35(3):275-8. PubMed ID: 21537148
[TBL] [Abstract][Full Text] [Related]
12. Comparison of radiolabeled monoclonal antibody and magnetic resonance imaging in the detection of metastatic neuroblastoma in bone marrow: preliminary results.
Fletcher BD; Miraldi FD; Cheung NK
Pediatr Radiol; 1989; 20(1-2):72-5. PubMed ID: 2602020
[TBL] [Abstract][Full Text] [Related]
13. Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients.
van Wezel EM; Decarolis B; Stutterheim J; Zappeij-Kannegieter L; Berthold F; Schumacher-Kuckelkorn R; Simon T; Fiocco M; van Noesel MM; Caron HN; van der Schoot CE; Hero B; Tytgat GAM
Eur J Cancer; 2016 Feb; 54():149-158. PubMed ID: 26796600
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic value of the determination of bone marrow lesion in patients with neuroblastoma based on the gene PHOX2B and TH expression].
Druĭ AE; Shorikov EV; Tsaur GA; Popov AM; Tuponogov SN; Savel'ëv LI; Tsvirenko SV; Fechina LG
Vopr Onkol; 2014; 60(2):57-62. PubMed ID: 24919263
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of initial bone marrow disease detection by multiparameter flow cytometry in children with neuroblastoma.
Popov A; Druy A; Shorikov E; Verzhbitskaya T; Solodovnikov A; Saveliev L; Tytgat GAM; Tsaur G; Fechina L
J Cancer Res Clin Oncol; 2019 Feb; 145(2):535-542. PubMed ID: 30603901
[TBL] [Abstract][Full Text] [Related]
16. Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma.
Li P; Gao Y; Ji Z; Zhang X; Xu Q; Li G; Guo Z; Zheng B; Guo X
J Pediatr Surg; 2004 Oct; 39(10):1512-9. PubMed ID: 15486896
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Persistent Tumor in Bone Marrow during Treatment of High-risk Neuroblastoma.
Choi YB; Bae GE; Lee NH; Kim JS; Lee SH; Yoo KH; Sung KW; Koo HH
J Korean Med Sci; 2015 Aug; 30(8):1062-7. PubMed ID: 26240483
[TBL] [Abstract][Full Text] [Related]
18. Impact of minimal residual disease detection prior to autologous stem cell transplantation for post-transplant outcome in high risk neuroblastoma.
Bochennek K; Esser R; Lehrnbecher T; Glienke W; Wehner S; Erben S; Soerensen J; Schwabe D; Bader P; Klingebiel T; Koehl U
Klin Padiatr; 2012 Apr; 224(3):139-42. PubMed ID: 22377741
[TBL] [Abstract][Full Text] [Related]
19. Prognostic influence of minimal residual disease detected by flow cytometry and peripheral blood stem cell transplantation by CD34+ selection in childhood advanced neuroblastoma.
Cai JY; Tang YJ; Jiang LM; Pan C; Chen J; Tang JY
Pediatr Blood Cancer; 2007 Dec; 49(7):952-7. PubMed ID: 17514736
[TBL] [Abstract][Full Text] [Related]
20. Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis.
Marachelian A; Villablanca JG; Liu CW; Liu B; Goodarzian F; Lai HA; Shimada H; Tran HC; Parra JA; Gallego R; Bedrossian N; Young S; Czarnecki S; Kennedy R; Weiss BD; Goldsmith K; Granger M; Matthay KK; Groshen S; Asgharzadeh S; Sposto R; Seeger RC
Clin Cancer Res; 2017 Sep; 23(18):5374-5383. PubMed ID: 28559462
[No Abstract] [Full Text] [Related]
[Next] [New Search]
